Laboratory Evaluation of FR10024, a New Cephalosporin Derivative

FR10024 is a broad-spectrum antibiotic. The in vitro antibacterial activity of FR10024 against clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis is greater than that of any of the cephalosporins developed to date. Indole-positive Proteus, Ente...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Nishida, Minoru, Murakawa, Takeo, Kamimura, Toshiaki, Okada, Naohiko, Fukada, Shigemi, Sakamoto, Hiroshi, Nakamoto, Shoji, Yokota, Yoshiko, Kono, Yoko
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1977
Teme:	Pharmacology and Therapeutics
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351918/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/836014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.1.51
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!